App aims to help diabetes patients protect kidneys through diet
NCT ID NCT07485075
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a smartphone app called StenoFood that gives dietary advice and self-monitoring tools to people with type 2 diabetes and early kidney disease. The goal is to see if the app helps them follow low-sodium and moderate-protein diet guidelines. About 104 participants will use the app for 6 months, and researchers will measure changes in salt and protein intake through urine tests.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
StenoFood App (digital patient education program with dietary guidance and self-monitoring tools)
What this could lead to
If successful, this app could become a simple, scalable tool to help people with type 2 diabetes and kidney disease stick to recommended diets, potentially slowing kidney decline.
What could go wrong
This is a small, early-stage study (104 participants) focused on dietary adherence, not hard outcomes like kidney failure. The app may not improve health or be easy for everyone to use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES TYPE 2 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nordsjællands Hospital, Hillerød
RECRUITINGHillerød, Captial Region of Denmark, 3400, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Steno Diabetes Center Copenhagen,
RECRUITINGHerlev, Captial Region of Denmark, 2730, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact